120
Participants
Start Date
October 31, 2012
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
EDWARDS INTUITY
To evaluate cardiac performance characteristics and adverse events rates associated with the EDWARDS INTUITY Valve in patients undergoing AVR \& CABG.
Stented aortic bioprostheses
In comparison to control valves available on the market.
CHU Bordeaux, Hôpital Haut-Lévêque, Pessac
Lead Sponsor
Edwards Lifesciences
INDUSTRY